recombinant human follicle-stimulating hormone
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for recombinant human follicle-stimulating hormone, covering 2012-06-20 to 2012-06-20. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Outcomes in WHO Type I Anovulatory Women Using r-hFSH+r-hLH in a 2:1 Ratio or hMG-HP [NA]